Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection†‡Richard K. Sterling, Mark Nelson, Eduardo Lissen et al.|Hepatology|2006Cited by 4.8k
Sofosbuvir for Hepatitis C Genotype 2 or 3 in Patients without Treatment OptionsIra M. Jacobson, David R. Nelson, Stuart C. Gordon et al.|New England Journal of Medicine|2013Cited by 1.1k
Ledipasvir and Sofosbuvir Plus Ribavirin for Treatment of HCV Infection in Patients With Advanced Liver DiseaseMichael Charlton, Atif Zaman, Gregory T. Everson et al.|Gastroenterology|2015Cited by 799
Hepatotoxicity associated with nevirapine or efavirenz-containing antiretroviral therapy: Role of hepatitis C and B infectionsMark Sulkowski, Richard D. Moore, David L. Thomas et al.|Hepatology|2002Cited by 521
Care of patients with chronic hepatitis C and HIV co-infection: recommendations from the HIV–HCV International PanelVincent Soriano, Jürgen Rockstroh, Mark Sulkowski et al.|AIDS|2002Cited by 443